Patients in the ratutrelvir arm received ratutrelvir 600 mg orally once daily for 10 days, while patients in the comparator ...

Traws Pharma reports interim Phase 2 data showing ratutrelvir performed comparably to Paxlovid in mild-to-moderate COVID-19 ...

The "United States Multiple Myeloma Market Report by Drugs Types, Disease Types, End User, States and Company Analysis, 2025-2033" has been added to ResearchAndMarkets.com's offering.The United States ...

This important study identifies PRRT2 as an auxiliary regulator of Nav channel slow inactivation, proposing that PRRT2 facilitates entry into, and delays recovery from, the slow-inactivated state. The ...

Cocrystal Pharma ( ($COCP) ) has shared an announcement. On December 18, 2025, Cocrystal Pharma announced that the Institutional Review Board at ...

Traws Pharma (TRAW) announced that interim data with ratutrelvir, an investigational oral, ritonavir-free Mpro/3CL protease inhibitor, ...

Foods high in protein and fiber are better at holding off hunger—that can include eggs, fatty fish, oatmeal, and more.

Subject enrollment expected to begin in Q1 2026CDI-988 is the first oral broad-spectrum antiviral drug candidate for ...

Researchers have identified existing compounds that block the coronavirus Mpro enzyme, including a potent molecule called 5b.

Experts warn that poor sugar control pushes HIV-related health risks higher, leading to faster progression of heart, kidney and nerve problems: Poor Diabetes Management ...

KALA BIO, Inc. (NASDAQ:KALA) (“KALA” or the “Company”), today announced the closing of its previously announced registered ...

Evercore 8th Annual Healthcare Conference December 3, 2025 10:50 AM ESTCompany ParticipantsDietmar Berger - Chief ...